app_store_button

google_play_button

DK - Details page - Device banner - 894x1036

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

Lyt når som helst, hvor som helst 

BBC Radio 4


Series that demystifies health issues, separating fact from fiction and bringing clarity to conflicting health advice.


Inside Health

Penis fillers were an unexpected talking point at the recent Winter Olympics after claims that male ski jumpers were having them to improve performance.

So this week we’re digging into the UK’s penis filler industry.

James visits a private clinic in Manchester to hear about about the procedure, which involves hyaluronic acid being injected to temporarily increase penis girth. 

He meets Jason, who had his first penis filler five months’ ago, and he explains why he wanted it and how he weighed up the risks versus the benefits.

James also chats to an NHS surgeon who says increasing numbers of men are seeking out the procedure - and he is dealing with the consequences when it goes wrong.

Also this week, why is aspirin in short supply? 

Presenter: James Gallagher
Producer: Gerry Holt
Editor: Ilan Goodman
Production coordinator: Stuart Laws 
Sound engineer: Emma Harth

 The show was made by the BBC’s Audio Science Unit in collaboration with The Open University.

Why are men getting penis fillers?

ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape.
 
The emergence of Long COVID – a condition with striking similarities to ME – has accelerated scientific interest and opened new lines of inquiry into the underlying biology of both illnesses.

In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID.
 
James also hears from Catherine and Jo, who have lived with ME for many years. They describe their diagnostic journeys and how they manage their symptoms in their daily lives. 

Presenter: James Gallagher 
Producer: Alice Lipscombe-Southwell 
Researcher: Tom Hunt 
Editors: Erika Wright and Ilan Goodman

Is the tide turning on ME research?

Over 1.5million adults in the UK tried weight loss drugs in 2024-25. Many swear by them, but they have been associated with side effects including nausea and, in some cases, extremely painful gallstones. But what does the evidence actually tell us, and what is the wider impact on the way we view our bodies in society?

James Gallagher is joined by Professor of Cardiometabolic Medicine at the University of Glasgow Naveed Sattar, Dr Beverley O’Hara, Lecturer in Public Health Nutrition at Leeds Beckett University, and Dr Margaret McCartney, resident Inside Health GP. They discuss what the evidence tells us about the potential known side effects of these weight loss drugs, and the potential impact their use has on our view of obesity as a society. We also hear from Sarah Le Brocq, who has struggled with obesity all her adult life and has been on these drugs for the past 2-3 years about her experiences. 

Margaret McCartney has no conflicts of interest to declare.

Beverley O’Hara has no conflicts of interest to declare. She has 2 roles with the Association for the Study of Obesity (voluntary academic positions).

Naveed Sattar has consulted for and/or received speaker honoraria from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gan & Lee, GlaxoSmithKline, Hanmi Pharmaceuticals, Kailera, Mass Medicines, Menarini-Ricerche, Metsera, Novo Nordisk, Pfizer, Regeneron, Roche, UCB Pharma, and Verdiva Bio; and received grant support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche.

Presenter: James Gallagher
Producer: Hannah Fisher
Researcher: Tom Hunt 
Production coordinator: Stuart Laws
Content Editor: Ilan Goodman

What are the side effects of weight loss drugs?

Dentistry is high on the public and political agenda. There have been dozens of headlines about access to NHS dentistry, with some people having to travel huge distances to find a dentist, or being put onto long waiting lists to get an NHS appointment. 

In this episode of Inside Health, James Gallagher is joined by chairman of the British Dental Association Eddie Crouch, the Oral Health Foundation's Dr Rachael England, and consultant oral surgeon Tom Thayer. Together, they drill into the issues surrounding NHS dentistry. Along the way, they discuss possible solutions, whether contract reforms will help, and the potential future of dentistry in the UK. 

Presenter: James Gallagher
Producers: Alice Lipscombe-Southwell and Thomas Hunt
Production coordinator: Stuart Laws
Content editor: Ilan Goodman

Why is it so hard to find an NHS dentist?

Most of us have Epstein-Barr Virus (EBV) hiding in our bodies. 

You may know it as the cause of glandular fever or “kissing disease”. 

But more research is suggesting that it can turn our immune systems against us to cause autoimmune disease, such as multiple sclerosis or lupus. 
 
So, what is the virus doing in our bodies - and can we do anything about it? 

James is joined by Dr Claire Shannon-Lowe, a virologist at the University of Birmingham, and Dr Patrick Kearns from the University of Edinburgh, a neurologist and epidemiologist.

And we delve into the world of echolocation. 

Bats hunt at night by making pulses of sounds and listening to the echoes so they can build a picture of the world around them in total darkness - and it's a technique some people with visual impairment use to explore the world.

A team at the University of East Anglia has been testing how well humans can pick up these skills, so James pays a visit to have a go...

Presenter: James Gallagher
Producers: Gerry Holt, Tom Bonnett & Thomas Hunt
Production coordinator: Stuart Laws
Content editor: Ilan Goodman

Unlocking the mystery of Epstein-Barr Virus

This week we’re looking at government plans to start sequencing the DNA of every newborn baby in England within the next decade. 

Each newborn would undergo whole genome sequencing to assess their risk of hundreds of diseases, under NHS plans.

It promises a revolution in spotting disease early - but are there also risks?

And use of nicotine pouches is rising, especially among young men. 

But these little sachets that fit under the top lip aren’t yet regulated – so what do we know about the potential harms? 

Finally, as the cold weather continues, James gets a lesson in walking like a penguin to see if it helps avoid trips, slips and falls…
 
Presenter: James Gallagher
Producers: Tom Bonnett, Alice-Lipscombe-Southwell and Thomas Hunt
Production coordinator: Stuart Laws
Content editor: Ilan Goodman

Should all babies have their genome sequenced at birth?

James Gallagher stands by four lanes of traffic and inhales exhaust fumes all to see if he can see air pollution in his body. He looks at an intriguing finding that an mRNA vaccine might benefit people being treated with immunotherapy for some cancers and could we be on the cusp of a holy grail in dentistry? A breakthrough could mean we will soon be able to replace the enamel on our teeth.
 
Presenter: James Gallagher
Producer: Tom Bonnett
Researcher: Thom Hunt
Editor: Ilan Goodman

Where does air pollution go inside our body?

Saunas are popping up all over the country, with many people claiming they relax muscles and help ease stress. But what does the science say? This week, James Gallagher travels to Môr A Sawna in Jackson’s Bay, Barry, where he treats himself to a sauna session and undergoes a number of physical tests to find out what benefits the sweaty heat could offer. 

Next up, James visits The Advanced Neuropathies Centre in Cardiff to speak with Professor Liam Gray, a surgeon who is leading a pioneering treatment for Huntington’s disease. 

Presenter: James Gallagher 
Producers: Alice Lipscombe-Southwell and Gerry Holt 
Researcher: Tom Hunt 
Editor: Ilan Goodman 
Production coordinator: Stuart Laws

This episode was produced in partnership with The Open University.

Can working up a sweat in a sauna improve your health?

In 1964, the future for children born with Cystic Fibrosis was grim - most faced a life cut tragically short. Today, the majority of people living with CF in the UK are adults, a testament to extraordinary medical progress.

We meet Annabelle who lives with Cystic Fibrosis, and once believed she might not see her 18th birthday. And we hear from Dr Imogen Felton, a respiratory consultant at Royal Brompton Hospital, with expertise in cystic fibrosis, who tells us about the therapies crucial to this extended prognosis. 

The EDITH trial (Early Detection using Information Technology in Health) is testing how AI can help radiologists identify breast cancer at an earlier stage, transforming the future of diagnosis. We speak to Professor Sian Taylor-Philips, Professor of Population Health at the University of Warwick and co-leader of the trial.

In 2024, participation in Run Clubs across the UK surged by 64%. But does running in a group lead to better performance? To find out, James laces up for a jog around Hyde Park with the Monday Mood Booster Run Club and speaks with Arran Davis, a postdoctoral researcher at the University of Oxford, who’s exploring the links between social interaction and physical activity.

Presenter: James Gallagher
Producers: Debbie Kilbride, Minnie Harrop & Tom Bonnett
Editor: Ilan Goodman
Production coordinator: Ishmael Soriano
This episode was produced in partnership with The Open University.

The Revolution in Cystic Fibrosis Care That is Changing Lives

Dementia is now the UK’s leading cause of death - but could a vaccine one day help prevent it? New data from Wales suggests the shingles vaccine is linked to a 20% lower risk of developing dementia in later life, adding to evidence that viral infections can influence brain health.

Dr. Pascal Geldsetzer, Assistant Prof of Medicine at Stanford University discusses his findings and the further evidence required to prove this link, along with Prof Tara Spires-Jones, Group Leader in the UK Dementia Research Institute.

The UK has begun using the world’s first gonorrhoea vaccine - though it was originally developed for meningitis. With antibiotic-resistant strains increasing, we speak to Dr Suneeta Soni about why gonorrhoea has been so hard to target with vaccines.

At the Bristol Robotics Lab, engineers are creating devices to support mobility in older age. James meets Jonathan Rossner and tries out “The Right Trousers” - an inflatable exoskeleton designed to help people walk and to strengthen their muscles.

Presenter: James Gallagher
Producers: Debbie Kilbride, Tom Bonnett & Minnie Harrop
Editor: Ilan Goodman
Production coordinator: Ishmael Soriano
This episode was produced in partnership with The Open University.

Unlocking the mystery of Epstein-Barr Virus

Lyt når som helst, hvor som helst

Other podcasts you might like ...